NKGen Biotech, Inc. Warrants
NKGNW
NKGNW was delisted on the 4th of March, 2025.
26 hedge funds and large institutions have $268K invested in NKGen Biotech, Inc. Warrants in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
68% more capital invested
Capital invested by funds: $159K → $268K (+$108K)
10% less funds holding
Funds holding: 29 → 26 (-3)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$36.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.08K |
| 3 |
FTUS
Flow Traders U.S.
New York
|
+$666 |
| 4 |
SFA
Sequoia Financial Advisors
Akron,
Ohio
|
+$589 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$9.07K |
| 2 |
Walleye Capital
New York
|
-$3.25K |
| 3 |
FBCM
Fort Baker Capital Management
Larkspur,
California
|
-$2.61K |
| 4 |
Walleye Trading
New York
|
-$1.83K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$681 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
26
CAAS Capital Management
New York
| $1K | – | – | – |
|
|
SCM
27
Shaolin Capital Management
Miami,
Florida
| – | -$9.07K | -128,274 | Closed |
|
|
CAC
28
Cowen and Company
New York
| – | -$6.2K | -87,717 | Closed |
|
|
29
Walleye Capital
New York
| – | -$3.25K | -45,913 | Closed |
|
|
FBCM
30
Fort Baker Capital Management
Larkspur,
California
| – | -$2.61K | -36,934 | Closed |
|
|
31
Walleye Trading
New York
| – | -$1.83K | -25,830 | Closed |
|
NKGNW Hedge Fund Activity: Q4 2024 in Review
26 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q4 2024, worth a combined $268K — up 68% from $159K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of NKGNW and 2 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Magnetar Financial, opening a new position worth an estimated $36.4K. The largest seller was Shaolin Capital Management, exiting entirely with an estimated $9.07K sold.
- 26 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q4 2024, down from 29 in Q3 2024.
- Funds reported $268K of NKGen Biotech, Inc. Warrants stock for Q4 2024, up 68% quarter-over-quarter.
- 2 funds opened new NKGen Biotech, Inc. Warrants positions in Q4 2024 and 5 closed out, a net change of -3 holders.
- The largest NKGen Biotech, Inc. Warrants buyer in Q4 2024 was Magnetar Financial, an estimated $36.4K added.
- The largest NKGen Biotech, Inc. Warrants seller in Q4 2024 was Shaolin Capital Management, an estimated $9.07K sold.
Based on aggregated 13F filings for Q4 2024.